Table 2

Specificity of EBV-specific CTL lines

Patient IDHLA typeSpecificity
EBNA 3A-CLYTICLMP2
P1507 A11, 24; B18, 40 ++++ (A11, 24)   
P1560 A01, 24; B08, 47   ++ (A24) 
P1641 A02, 68; B44, 49 *  +(B68) 
P1668 A24; B40, 45 +++ (A24)  ++ (A24) 
P1708 A3; B27, 45 +++ (B27)   
P1740 A01, 02; B27, 37  +++ (A2) ++ (A2) 
P1790 A01, 25; B08, 38 + (B8) +++ (B8) ++  
P1798 A11, 24; B13, 51    
Patient IDHLA typeSpecificity
EBNA 3A-CLYTICLMP2
P1507 A11, 24; B18, 40 ++++ (A11, 24)   
P1560 A01, 24; B08, 47   ++ (A24) 
P1641 A02, 68; B44, 49 *  +(B68) 
P1668 A24; B40, 45 +++ (A24)  ++ (A24) 
P1708 A3; B27, 45 +++ (B27)   
P1740 A01, 02; B27, 37  +++ (A2) ++ (A2) 
P1790 A01, 25; B08, 38 + (B8) +++ (B8) ++  
P1798 A11, 24; B13, 51    

Frequency: ++++, 1-2%; +++, 0.5-1%; ++, 0.25-0.5%; +, < 0.25%.

*

No epitopes.

HLA restriction unknown.

or Create an Account

Close Modal
Close Modal